September 10, 2013 -
CROS NT specializes in work regarding biometric services and Stat-Tech Services works mostly in the medical devices sector, but also has significant expertise with biometrics. The terms of this deal have not been disclosed.
“I am delighted to welcome Stat‐Tech services into the family,” Paolo Morelli, CROS NT’s president and CEO said. “The experience and quality of the Stat‐Tech team will add strong value to CROS NT, adding the important area of medical devices to our portfolio and allowing us to improve our services to our existing US customers by being closer to them. I was impressed by the reputation of their management and their strong leadership, which we can combine with the existing groups in Europe to field a great team globally.”
“I believe that having highly qualified specialists delivers the best results when conducting clinical trials. CROS NT remains focused on biometrics and by providing expert data services, it allows its customers to work with clinical CROs appropriate to their therapeutic or geographic needs. We take care of the data collection, the reporting and provide centralized data solutions to maximize the value of that data for the customer.”
Under the new deal, Stat-Tech will operate as a business line within CROS NT, and the transaction is set to be completed later this month.
Reported previously, CROS NT recently joined the DATATRAK Connect program, which aims to accelerate the drug development practice with an aim to reduce study costs and further business development.